Literature DB >> 21243014

Cancer: do aspirin and other NSAIDs protect against colorectal cancer?

Sarah Kraus, Nadir Arber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21243014     DOI： 10.1038/nrgastro.2010.217

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

Review 1.  Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.

Authors:  Farhat V N Din; Evropi Theodoratou; Susan M Farrington; Albert Tenesa; Rebecca A Barnetson; Roseanne Cetnarskyj; Lesley Stark; Mary E Porteous; Harry Campbell; Malcolm G Dunlop
Journal:  Gut       Date:  2010-09-15       Impact factor: 23.059

2.  Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

Authors:  Nancy R Cook; I-Min Lee; J Michael Gaziano; David Gordon; Paul M Ridker; JoAnn E Manson; Charles H Hennekens; Julie E Buring
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

3.  A randomized trial of aspirin to prevent colorectal adenomas.

Authors:  John A Baron; Bernard F Cole; Robert S Sandler; Robert W Haile; Dennis Ahnen; Robert Bresalier; Gail McKeown-Eyssen; Robert W Summers; Richard Rothstein; Carol A Burke; Dale C Snover; Timothy R Church; John I Allen; Michael Beach; Gerald J Beck; John H Bond; Tim Byers; E Robert Greenberg; Jack S Mandel; Norman Marcon; Leila A Mott; Loretta Pearson; Fred Saibil; Rosalind U van Stolk
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

Review 4.  The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Authors:  Catherine Dubé; Alaa Rostom; Gabriela Lewin; Alexander Tsertsvadze; Nicholas Barrowman; Catherine Code; Margaret Sampson; David Moher
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

5.  Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.

Authors:  Christine Cole Johnson; Richard B Hayes; Robert E Schoen; Marc J Gunter; Wen-Yi Huang
Journal:  Am J Gastroenterol       Date:  2010-08-31       Impact factor: 10.864

6.  Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Authors:  Bernard F Cole; Richard F Logan; Susan Halabi; Robert Benamouzig; Robert S Sandler; Matthew J Grainge; Stanislas Chaussade; John A Baron
Journal:  J Natl Cancer Inst       Date:  2009-02-10       Impact factor: 13.506

Review 7.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

Authors:  Enrico Flossmann; Peter M Rothwell
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

8.  Low-dose aspirin and incidence of colorectal tumors in a randomized trial.

Authors:  P H Gann; J E Manson; R J Glynn; J E Buring; C H Hennekens
Journal:  J Natl Cancer Inst       Date:  1993-08-04       Impact factor: 13.506

Review 9.  Chemoprevention of colorectal neoplasia: the potential for personalized medicine.

Authors:  Nadir Arber; Bernard Levin
Journal:  Gastroenterology       Date:  2008-04       Impact factor: 22.682

Review 10.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

Authors:  Jack Cuzick; Florian Otto; John A Baron; Powel H Brown; John Burn; Peter Greenwald; Janusz Jankowski; Carlo La Vecchia; Frank Meyskens; Hans Jörg Senn; Michael Thun
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316
  10 in total
  4 in total

Review 1.  Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states.

Authors:  Kristoffer Watten Brudvik; Kjetil Taskén
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid.

Authors:  Xiaobo Zhang; Seong-Ho Lee; Kyung-Won Min; Michael F McEntee; Jin Boo Jeong; Qingwang Li; Seung Joon Baek
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-08

3.  Protein kinase A antagonist inhibits β-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min/+) mice.

Authors:  Kristoffer W Brudvik; Jan E Paulsen; Einar M Aandahl; Borghild Roald; Kjetil Taskén
Journal:  Mol Cancer       Date:  2011-12-15       Impact factor: 27.401

Review 4.  Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units.

Authors:  Vanessa L Wehbi; Kjetil Taskén
Journal:  Front Immunol       Date:  2016-06-08       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.